tirzepatide surmount-1 weight loss percent 72 weeks Lilly released results for SURMOUNT-2, a trial of in people with T2D and obesity or overweight at weeks: ๐10 mg: -13.4% BW ๐15 mg: -15.7% BW โญ๏ธImportant: at SURMOUNT-1 in @nejm๐ โฐ72-week trial
Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 22 - Aug 27




























